Upfront treatment with <scp>mTOR</scp> inhibitor everolimus in pediatric low‐grade gliomas: A single‐center experienceAntonella Cacchione(Bambino Gesù Children's Hospital), Angela Mastronuzzi(Bambino Gesù Children's Hospital)International Journal of CancerDecember 20, 202010.1002/ijc.33438Cited by 19SaveCiteExport RISWatch citationsRelated PapersIDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma|Oncotarget|2016|41The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors|Frontiers in Immunology|2023|22